Next Article in Journal
Autophagy Proteins in Viral Exocytosis and Anti-Viral Immune Responses
Next Article in Special Issue
Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4+ T Cells
Previous Article in Journal
Assessing Monkeypox Virus Prevalence in Small Mammals at the Human–Animal Interface in the Democratic Republic of the Congo
Previous Article in Special Issue
Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era
Open AccessBrief Report

Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference

1
Department of Medicine, Lady Davis Institute-Jewish General Hospital, McGill University, Montreal, QC, H3T 1E2, Canada
2
Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA
3
School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, Hebei 050017, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Viruses 2017, 9(10), 287; https://doi.org/10.3390/v9100287
Received: 6 September 2017 / Revised: 28 September 2017 / Accepted: 1 October 2017 / Published: 3 October 2017
(This article belongs to the Special Issue Homage to Mark Wainberg)
Flaviviruses including Zika, Dengue and Hepatitis C virus cause debilitating diseases in humans, and the former are emerging as global health concerns with no antiviral treatments. We investigated Sophora Flavecens, used in Chinese medicine, as a source for antiviral compounds. We isolated Sophoraflavenone G and found that it inhibited Hepatitis C replication, but not Sendai or Vesicular Stomatitis Virus. Pre- and post-infection treatments demonstrated anti-flaviviral activity against Dengue and Zika virus, via viral RNA polymerase inhibition. These data suggest that Sophoraflavenone G represents a promising candidate regarding anti-Flaviviridae research. View Full-Text
Keywords: flavivirus; Zika virus; Dengue virus; antiviral; therapy; RNA polymerase flavivirus; Zika virus; Dengue virus; antiviral; therapy; RNA polymerase
Show Figures

Figure 1

MDPI and ACS Style

Sze, A.; Olagnier, D.; Hadj, S.B.; Han, X.; Tian, X.H.; Xu, H.-T.; Yang, L.; Shi, Q.; Wang, P.; Wainberg, M.A.; Wu, J.H.; Lin, R. Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference. Viruses 2017, 9, 287. https://doi.org/10.3390/v9100287

AMA Style

Sze A, Olagnier D, Hadj SB, Han X, Tian XH, Xu H-T, Yang L, Shi Q, Wang P, Wainberg MA, Wu JH, Lin R. Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference. Viruses. 2017; 9(10):287. https://doi.org/10.3390/v9100287

Chicago/Turabian Style

Sze, Alexandre; Olagnier, David; Hadj, Samar B.; Han, Xiaoying; Tian, Xiao H.; Xu, Hong-Tao; Yang, Long; Shi, Qingwen; Wang, Penghua; Wainberg, Mark A.; Wu, Jian H.; Lin, Rongtuan. 2017. "Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference" Viruses 9, no. 10: 287. https://doi.org/10.3390/v9100287

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop